TuHURA Biosciences
HURA
9 hedge funds and large institutions have $291K invested in TuHURA Biosciences in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 2 closing their positions.
77% more capital invested
Capital invested by funds: $164K → $291K (+$127K)
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
13% more funds holding
Funds holding: 8 → 9 (+1)
0.05% more ownership
Funds ownership: 0.07% → 0.12% (+0.05%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$95.3K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$52.5K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$885 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$13.4K |
| 2 |
JP Morgan Chase
New York
|
-$2.25K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$443 |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$262 |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$148 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
NCM
1
Nantahala Capital Management
New Canaan,
Connecticut
| $91.4K | +$95.3K | +646 | New |
|
|
2
Geode Capital Management
Boston,
Massachusetts
| $56.4K | -$443 | -3 | -0.7% |
|
|
3
Vanguard Group
Malvern,
Pennsylvania
| $50.3K | +$52.5K | +356 | New |
|
4
State Street
Boston,
Massachusetts
| $43.4K | – | – | – |
|
5
Acadian Asset Management
Boston,
Massachusetts
| $25K | – | – | – |
|
6
Morgan Stanley
New York
| $13.5K | – | – | – |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $6.33K | -$13.4K | -91 | -67% |
|
|
8
Osaic Holdings
Scottsdale,
Arizona
| $3.83K | -$148 | -1 | -4% |
|
|
9
Bank of America
Charlotte,
North Carolina
| $808 | +$885 | +6 | New |
|
10
Wells Fargo
San Francisco,
California
| $48 | – | – | – |
|
|
11
JP Morgan Chase
New York
| – | -$2.25K | -16 | Closed |
|
|
12
UBS Group
Zurich,
Switzerland
| – | -$262 | -2 | Closed |
|
HURA Hedge Fund Activity: Q3 2023 in Review
9 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in TuHURA Biosciences (HURA) for Q3 2023, worth a combined $291K — up 77% from $164K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new HURA positions and 2 closed out — a net gain of 1 holder — while 0 added to existing stakes and 3 trimmed.
The largest buyer was Nantahala Capital Management, opening a new position worth an estimated $95.3K. The largest seller was Tower Research Capital (TRC), cutting an estimated $13.4K.
- 9 institutional investors held TuHURA Biosciences (HURA) as of Q3 2023, up from 8 in Q2 2023.
- Funds reported $291K of TuHURA Biosciences stock for Q3 2023, up 77% quarter-over-quarter.
- 3 funds opened new TuHURA Biosciences positions in Q3 2023 and 2 closed out, a net change of +1 holder.
- The largest TuHURA Biosciences buyer in Q3 2023 was Nantahala Capital Management, an estimated $95.3K added.
- The largest TuHURA Biosciences seller in Q3 2023 was Tower Research Capital (TRC), an estimated $13.4K sold.
Based on aggregated 13F filings for Q3 2023.